巨星傳奇IPO:新零售背後的長尾流量

HONG KONG, Nov 29, 2022 – (亞太商訊 via SEAPRWire.com) – 據證券日報報道,近日,吸引了全球目光的世界杯比賽正進行得“如火如荼”,此前的11月19日,《周遊記2》宣布再次啟程,預告片中,瘦身後的周杰倫和好友們比拼花式足球、魔術足球,吸引了大量粉絲關注…

JBM Healthcare Announces FY2023 Interim Results

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – JBM (Healthcare) Limited (“JBM Healthcare” or the “Group”; Stock Code: 2161), a leading branded healthcare products marketer and distributor in Hong Kong, has announced today the interim results of the Group for the six months ended 30 September 2022 (the “Reporting Period”). KEY HIGHLIGHTS— […]

天大藥業公布2022/23年度中期業績

HONG KONG, Nov 25, 2022 – (亞太商訊 via SEAPRWire.com) – 天大藥業有限公司 (「天大藥業」或「集團」;股份代號:0455.HK)今天公布截至2022年9月30日止六個月(「期內」)之中期業績。期內,集團採取積極營銷策略,業績表現明顯進步,收入按年增…

健倍苗苗公佈二零二三財年中期業績

HONG KONG, Nov 25, 2022 – (亞太商訊 via SEAPRWire.com) – 健倍苗苗(保健)有限公司 (「健倍苗苗」或「集團」;股份代號:2161.HK) 為香港領先的品牌醫療保健品推廣商及分銷商,集團今天公佈截至二零二二年九月三十日止六個月(「報告期」)的中期業績…

雅各臣公佈二零二三財年中期業績

HONG KONG, Nov 25, 2022 – (亞太商訊 via SEAPRWire.com) – 從事基礎藥物、專科藥物及品牌醫療保健品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司 (「 雅各臣 」 或 「 公司 」;股份代號 2633.HK ) 今天公佈公司及其附屬…

Jacobson Pharma Announces FY2023 Interim Results

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – Jacobson Pharma Corporation Limited (“Jacobson Pharma” or the “Company”; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of essential medicines, specialty drugs and branded healthcare products, today announced the interim results of the Company and its subsidiaries […]

The Hong Kong Institute of Directors Holds Silver Jubilee Dinner and Presentation Ceremony for Directors Of The Year Awards 2022

HONG KONG, Nov 25, 2022 – (ACN Newswire via SEAPRWire.com) – The Hong Kong Institute of Directors (“HKIoD”) has announced the winners of the Directors Of The Year Awards (“DYA”) 2022. As the flagship project of HKIoD, DYA is one of the most prestigious business accolades in Hong Kong and the first of its kind […]

完美醫療公佈2022/23中期業績

HONG KONG, Nov 23, 2022 – (亞太商訊 via SEAPRWire.com) – 全球最大的醫療美容營運商之一,完美醫療健康管理有限公司(「完美醫療」或「公司」;股票代碼:1830.HK)連同其附屬公司(統稱「集團」)欣然宣佈其截至2022年9月30日止的中期業績。 業績…